Investor relations

Welcome to the Bioceltix Investor Relations page. This is an information hub for capital market participants, particularly shareholders, analysts, and individual and institutional investors interested in the Company’s activities. Information for the media is also available here.

Who we are

Bioceltix is a team of experts developing innovative therapies in veterinary medicine. We work on biological drugs that leverage the immunomodulatory properties of mesenchymal stem cells. Our therapies are developed according to the highest standards of quality and safety. We operate a state-of-the-art research and manufacturing facility, collaborate with ambitious scientists, and follow a well-designed business model. Our goal is to bring new, effective solutions to the veterinary medicine market.